Recombinant Human CCL27 Protein，His

CCL27, also known as cutaneous T cell-attracting chemokine, is a pivotal cytokine involved in skin immune responses and inflammatory skin diseases. Its primary function is to attract and activate T cells, particularly in the skin, making it crucial for both innate and adaptive immunity. The study of CCL27 is particularly significant in the context of dermatological disorders such as psoriasis, atopic dermatitis, and allergic contact dermatitis, where its expression is often dysregulated. Researchers have focused on the recombinant production of CCL27 protein to explore its biological effects and signaling pathways more thoroughly. The ability to generate recombinant CCL27 allows investigators to conduct in vitro and in vivo experiments, elucidating its role in T cell migration and skin inflammation. Additionally, understanding CCL27’s interactions with its receptor, CCR10, provides insights into potential therapeutic targets for managing skin diseases. In recent years, there has been growing interest in the role of CCL27 in cancer biology, particularly in skin cancers, further broadening its research implications. Overall, the exploration of recombinant CCL27 not only advances our fundamental understanding of skin immunology but also opens new avenues for the development of targeted treatments for skin-related conditions.